Tuesday, August 25, 2009

Thiolactomycin analogues as potential anti-Toxoplasma gondii agents

Parasitol Int. 2009 Aug 18. [Epub ahead of print]

Thiolactomycin analogues as potential anti-Toxoplasma gondii agents

Martins-Duarte ES, Jones SM, Gilbert IH, Atella GC, de Souza W, Vommaro RC.

Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, 21941-902 - Rio de Janeiro-RJ, Brazil.

The discovery of new compounds active against Toxoplasma gondii is extremely important due to the severe disease caused by this pathogen in immunocompromised hosts and to congenital infection. Type II fatty acid biosynthesis has shown to be a promising target for drug intervention in toxoplasmosis. Here we describe the inhibitory effect of 8 thiolactomycin (TLM) analogues against tachyzoite-infected LLC-MK(2) cells. The TLM analogues demonstrated anti-T. gondii activity, arresting tachyzoite proliferation with IC(50) values in the micromolar level after 24h and 48h of treatment. Metabolic labelling of extracellular parasites treated with TLM analogues using [(3)H]acetate demonstrated that these drugs affected acylglycerol synthesis. The rapid reduction of parasite load suggests that these compounds have selective cytotoxic effects against T. gondii. Transmission electron microscopy demonstrated that TLM analogues interfered with membrane-bounded organelles and parasite division and this in turn affected parasite development and survival.

PMID: 19698800 [PubMed - as supplied by publisher]

1 comment:

Joanna said...

The success of drug intervention programs results from a combined effort of families, friends and a professional drug interventionist.